HC Wainwright & Co. Reiterates Buy on Checkpoint Therapeutics, Maintains $34 Price Target
HC Wainwright & Co. Reiterates Buy on Checkpoint Therapeutics, Maintains $34 Price Target
HC Wainwright & Co.重申買入Checkpoint Therapeutics,維持34美元的目標價
HC Wainwright & Co. analyst Joseph Pantginis reiterates Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and maintains $34 price target.
HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯重申了Checkpoint Therapeutics(納斯達克股票代碼:CKPT)的買入並維持34美元的目標股價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。